ADA 2025 20 - 23 June 2025

Impact of Semaglutide on Kidney, Cardiovascular, and Mortality Outcomes by Baseline BMI and Weight Loss in People with T2D and CKD: Data from the FLOW Trial

Authors :

Johannes F. E. Mann^1,2; Katherine R. Tuttle^3,4; Richard E. Pratley⁵; Kenneth W. Mahaffey⁶; Mustafa Arici⁷; Nicolas Belmar⁸; Karen Bonefeld⁸; Gil Chernin⁹; Ricardo Correa-Rotter¹⁰; Pieter Gillard¹¹; Samy Hadjadj¹²; Thomas Idorn⁸; Linong Ji¹³; Soo Kun Lim¹⁴; Martin Linder⁸; Roland Schmieder¹⁵; Minara Shamkhalova¹⁶; Apiradee Sriwijitkamol¹⁷; Vlado Perkovic¹⁸; Peter Rossing¹⁹